AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2018
Jul 11, 2018
32414_dirs_2018-07-11_8dd1f5c3-f9cd-484a-9c02-e3ab76b458ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-07-09
Reporting Person: COLLERAN LISA N (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-09 | Stock Option (right to purchase) | $53.65 | A | 9134 | Acquired | 2028-07-09 | Common Stock (9134) | Direct |
| 2018-07-09 | Stock Option (right to purchase) | $53.65 | A | 3916 | Acquired | 2028-07-09 | Common Stock (3916) | Direct |
Footnotes
F1: Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on October 9, 2018 and becoming fully vested July 9, 2020 (two years after grant).
F2: Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests quarterly with all shares vested June 1, 2019 in conformity with vesting for such annual director grants.
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3